Thanks to the scale-up of malaria control measures, such as bed nets, insecticide spraying, diagnosis and effective medicines, malaria mortality has decreased by 60%, with 6.2 million lives saved since 2000. But despite this tremendous progress, still an estimated 3.4 billion people in 97 countries are at risk of malaria. Every year, an estimated 214 million people fall ill of malaria, and 438,000 people die of its consequences.

WHO global strategy and Roll Back Malaria action plan, aligned with the 2016-2030 timeline of the Sustainable Development Goals, provide concerted direction towards the ambitious 2030 malaria goals to reduce malaria mortality and case incidence compared with 2015 by 40% by 2020 and 90% by 2030 and to increase malaria-free countries by additional 10 and 35 countries by 2020 and 2030, respectively.

SDC’s contribution to the Swiss TPH Malaria Initiative through GlobMal phase 2 supports WHO’s normative role. It leverages credibility and political impact at the global level through interactions with WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, the new Roll Back Malaria Partnership, and reiterates continued Swiss support to the global malaria control and elimination effort.

The support to global malaria control and elimination by the SDC contributes to influencing global malaria policies and ultimately to reduce the malaria burden and to increase number of malaria-free zones.

Global malaria community through policy dialogue and technical expertise advancements

Malaria control managers from malaria endemic countries for capacity building

Ultimately, populations worldwide of all malaria endemic countries

Outcome 1: Technical evidence on vector control and malaria case management is generated and communicated in a concerted way via multistakeholder platforms promoting country, regional and global exchanges and coordination.

Outcome 2: A development approach for malaria is fostered via a multistakeholder platform promoting multisectoral approaches and action at global, regional and country levels.

Outcome 3: Human technical capacities for malaria control are strengthened in endemic countries through a concerted global approach to needs-based training.

Expected results:  

Output 1: The Vector Control Working Group (VCWG) is functional and provides effective support to the global malaria vector control efforts in all areas related to coordination and strategies

Output 2: The Case Management Working Group (CMWG) is functional and provides effective support to the global malaria case management efforts in all areas related to coordination and strategies

Output 3: A new working group on multisectoral action is built up and functional under the umbrella of RBM partnership

Output 4: An overall capacity building concept that is endorsed widely in the malaria community is developed

Output 5: Bi-annual regional, field and international courses are successfully carried out

Results from previous phases:  

The Roll Back Malaria Vector Control Working Group has generated evidence for guiding policy and has become the best attended and most dynamic Working Group, with more than 1,300 members and 250 participants attending the annual meeting in Geneva.

WHO-Global Malaria Programme strengthened through two technical staff – one in vector control and one in health economics –  with a great impact on World Malaria Report 2014 and 2015 by providing economic analysis and  developing the global normative and policy guidelines in vector control.

Training courses at international and regional level on malaria control and elimination have been successfully carried out by Swiss TPH.  GlobMal phase 2 builds on these previous successes and expands its activities.

Swiss TPH Malaria Initiative, a virtual center of all activities by Swiss TPH on malaria established.

WHO – Global Malaria Programme

Roll Back Malaria (RBM)

World Health Organization (WHO), Global Fund (GF), NETCELL, Foundation for Innovative New Diagnostics (FIND), Medicines for Malaria Venture (MMV), Innovative Vector Control Consortium (IVCC), WHO Special Programme on Tropical Disease Research (TDR), SDC chaired Swiss Malaria Group (SMG)

Phase 2 01.07.2016 - 30.06.2019   (Completed)